Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L
Alzheimer's Disease Research Laboratories, Suncoast Gerontology Center, Tampa, Florida.
Nat Genet. 1992 Aug;1(5):345-7. doi: 10.1038/ng0892-345.
Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.
先前已表明,β-淀粉样前体蛋白(APP)基因第17外显子717密码子处的突变在一些家族中与早发性阿尔茨海默病相关。我们在第16外显子中鉴定出670和671密码子处的双突变(APP 770转录本),该突变在来自瑞典的两个大型(可能相关)早发性阿尔茨海默病家族中与疾病共分离。与正常序列相比的两个碱基对颠换(G到T,A到C)预测APP转录本的670和671密码子处的氨基酸由赖氨酸变为天冬酰胺以及由甲硫氨酸变为亮氨酸。此突变发生在β-淀粉样蛋白的氨基末端,并且可能具有致病性,因为它发生在该分子的内体/溶酶体切割位点或其附近。因此,APP中的致病性突变构成了β-淀粉样蛋白序列。